Record Revenue Growth
OrthoPediatrics delivered record revenue of $54.6 million in Q3 2024, representing global growth of 37% from the same period in 2023.
Significant Increase in Children Helped
The company helped over 33,000 kids in Q3, a 50% increase year-over-year.
Scoliosis Segment Surge
Scoliosis revenue increased by 52% compared to the prior year, driven by strong case scheduling and new user onboarding.
Positive International Growth
International revenue grew by 12% year-over-year, with notable over 100% growth in international scoliosis.
Increased Guidance for 2024
Full-year 2024 revenue guidance was raised to $202-$204 million, indicating year-over-year growth of 36% to 37%.
New Product Launches
Successful launch of new products like PNP Tibia and DF2, with DF2 receiving additional FDA indication approval.